CENTESSA PHARMACEUTICALS PLC 152309100 06/20/2025 To receive and approve, on an advisory basis, the Company’s U.K. statutory directors’ remuneration report for the financial year ended December 31, 2024, which is set forth as Annex A to the proxy statement. SECTION 14A SAY-ON-PAY VOTES ISSUER 19963157 0 FOR 19963157 FOR 1 NEWAMSTERDAM PHARMA COMPANY N62509109 06/04/2025 Non-binding, advisory vote to approve the 2024 compensation of named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2869565 0 FOR 2869565 FOR 1 NEWAMSTERDAM PHARMA COMPANY N62509109 06/04/2025 Non-binding, advisory vote regarding frequency of future shareholders' advisory votes on the compensation of named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 2869565 0 1 YEAR 2869565 FOR 1 PHATHOM PHARMACEUTICALS INC 71722W107 06/03/2025 To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay"). SECTION 14A SAY-ON-PAY VOTES ISSUER 7464572 0 FOR 7464572 FOR 1 PHATHOM PHARMACEUTICALS INC 71722W107 06/03/2025 To approve a proposal for the frequency of future non-binding advisory votes on the compensation of the named executive officers ("say-on-frequency"). SECTION 14A SAY-ON-PAY VOTES ISSUER 7464572 0 1 YEAR 7464572 FOR 1 RAPT THERAPEUTICS INC 75382E208 05/29/2025 To approve, on an advisory basis, the compensation of RAPT Therapeutics, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 22352000 0 FOR 22352000 FOR 1 RAPT THERAPEUTICS INC 75382E208 05/29/2025 To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of RAPT Therapeutics, Inc.'s named executive officers. SECTION 14A SAY-ON-PAY VOTES ISSUER 22352000 0 1 YEAR 22352000 FOR 1